Ceritinib With Brentuximab Vedotin in Treating Patients With ALK-Positive Anaplastic Large Cell Lymphoma

Clinical trial NCT02729961 · WITHDRAWN

Trial details

NCT number: NCT02729961
Sponsor: University of Washington
Status: WITHDRAWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Anaplastic Large Cell Lymphoma, ALK-Positive CD30-Positive Neoplastic Cells Present Systemic Anaplastic Large Cell Lymphoma

Start date: 2018-01-03
Primary completion: 2023-07-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.